These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2853074)

  • 1. Non-selectivity of amitriptyline for subtypes of brain muscarinic receptors demonstrated in binding and functional assays.
    McKinney M; Lee NH; Anderson DJ; Vella-Rountree L; el-Fakahany EE
    Eur J Pharmacol; 1988 Nov; 157(1):51-60. PubMed ID: 2853074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses.
    Lee NH; Fryer AD; Forray C; el-Fakahany EE
    J Pharmacol Exp Ther; 1989 Dec; 251(3):992-9. PubMed ID: 2557423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Brown JH; Goldstein D; Masters SB
    Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the affinity of amitriptyline for muscarine receptor subtypes.
    Choi A; Mitchelson F
    Pharmacology; 1994 May; 48(5):293-300. PubMed ID: 8016190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective interaction of tricyclic antidepressants with a subclass of rat brain cholinergic muscarinic receptors.
    Nomura S; Zorn SH; Enna SJ
    Life Sci; 1987 May; 40(18):1751-60. PubMed ID: 3033413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
    McKinney M; Anderson D; Vella-Rountree L
    Mol Pharmacol; 1989 Jan; 35(1):39-47. PubMed ID: 2536467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of amitriptyline, doxepin, imipramine and their N-methyl quaternary ammonium derivatives with subtypes of muscarinic receptors in brain and heart.
    Ehlert FJ; Delen FM; Yun SH; Liem HA
    J Pharmacol Exp Ther; 1990 Apr; 253(1):13-9. PubMed ID: 2329499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors.
    Aagaard P; McKinney M
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1478-83. PubMed ID: 8263809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of [3H]telenzepine to muscarinic acetylcholine receptors in calf forebrain.
    Schudt C; Auriga C; Kinder B; Birdsall NJ
    Eur J Pharmacol; 1988 Jan; 145(1):87-90. PubMed ID: 3350039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secoverine is a non-selective muscarinic antagonist on rat heart and brain receptors.
    Brunner F; Waelbroeck M; Christophe J
    Eur J Pharmacol; 1986 Aug; 127(1-2):17-25. PubMed ID: 3758175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
    Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
    Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and binding studies with muscarinic M2-subtype selective antagonists.
    Lazareno S; Roberts FF
    Br J Pharmacol; 1989 Sep; 98(1):309-17. PubMed ID: 2804551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective agents for muscarinic receptors linked to phosphoinositide breakdown.
    Noronha-Blob L; Canning B; Costello D; Kinnier WJ
    Eur J Pharmacol; 1988 Sep; 154(2):161-7. PubMed ID: 2852597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
    Evans T; Smith MM; Tanner LI; Harden TK
    Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
    Miller JH; Aagaard PJ; Gibson VA; McKinney M
    J Pharmacol Exp Ther; 1992 Nov; 263(2):663-7. PubMed ID: 1331410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine.
    Giachetti A; Giraldo E; Ladinsky H; Montagna E
    Br J Pharmacol; 1986 Sep; 89(1):83-90. PubMed ID: 2432979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.